Johnson & Johnson partners with early-stage startups, focusing on series A investments in the biotech and health tech sectors. A notable portfolio company is Asgard Therapeutics. Committed to improving health outcomes, Johnson & Johnson leverages its expertise in medicine and medical technology to advance patient care. Their team of dedicated professionals aims to make a significant impact in healthcare.
